Skip to main content
    S

    Sionna Therapeutics, Inc. Common Stock (SION)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.07
    -0.05 (-1.60%)

    Market Cap: $141.13M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Sionna Therapeutics, Inc. Common Stock (SION) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sionna Therapeutics, Inc. Common Stock (SION) has a market cap of $141.13M and an enterprise value of $57.26M. It holds $83.88M more cash than debt, 59.43% of its market cap.

    Total Valuation

    Enterprise value is 59.43% below the market cap, as cash exceeds debt.

    Market Cap$141.13M
    Enterprise Value$57.26M
    Latest price (Nov 17, 2026)$3.07

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.13% in the quarter ended Sep 30, 2026 and grew 1.22% a year over 2 years.

    Shares Outstanding45.21M
    Shares Change (YoY)+2.16%
    Shares Change (QoQ)+0.13%
    Share Count Growth (2Y CAGR)+1.22%

    Price Statistics

    The stock is down 91.70% over 52 weeks and trades 35.37% below its 50-day average.

    Beta (1Y)1.75
    52-Week Change-91.70%
    1-Month Change-23.44%
    3-Month Change-50.88%
    6-Month Change-91.85%
    Total Return (1Y)-91.70%
    Return vs SPY (1Y)-103.71%
    Max Drawdown (1Y)-93.99%
    Sharpe Ratio (1Y)-1.00
    Correlation with SPY (1Y)0.09
    50-Day Average$4.75
    200-Day Average$27.82
    52-Week Range$3.10 to $54.97
    RSI (14 Days)28.8
    Average Volume (20 Days)829.14K

    Financial Position

    Current assets cover 13.92x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio13.92x
    Quick Ratio13.92x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -45.54% and return on assets is -41.60% over the last 12 months.

    Return on Equity (ROE)-45.54%
    Return on Assets (ROA)-41.60%

    Scores

    SION has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$152.00K
    Operating Income-$120.50M
    Pretax Income-$109.94M
    Net Income-$109.52M
    Reported EPS (TTM)-$2.44

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 91.36% of the $263.26M in total assets.

    Cash and Equivalents$83.88M
    Total Debt$0
    Net Cash$83.88M
    Net Cash Per Share$1.86
    Working Capital$212.11M
    Shareholder Equity$240.52M
    Book Value Per Share$5.32
    Total Assets$263.26M
    Total Liabilities$22.74M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$79.41M
    FCF Per Share-$1.76
    Depreciation and Amortization$1.53M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    SION does not pay a dividend.

    Buyback Yield0.42%
    Shareholder Yield0.42%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SION

    What is SION's market cap?

    Sionna Therapeutics, Inc. Common Stock has a market cap of $141.13M. Its enterprise value, which adds debt and subtracts cash, is $57.26M.

    How many shares of SION are outstanding?

    Sionna Therapeutics, Inc. Common Stock has 45.21M shares outstanding. The count is up 2.16% from a year earlier.

    Does SION pay a dividend?

    No. Sionna Therapeutics, Inc. Common Stock does not pay a dividend.

    How much debt does SION have?

    Sionna Therapeutics, Inc. Common Stock has $0 of total debt and $83.88M of cash and equivalents, a net cash position of $83.88M.